Products
FDA approves Amneal's prednisolone acetate ophthalmic suspension
Referencing Allergan's Pred Forte, this 1% concentrated drop is expected to hit the U.S. market by Q3 2025.
Products
Ocubio introduces personalized autologous serum eye drops
Based on a proprietary manufacturing protocol from Bascom Palmer, qASED uses patients’ blood in the formulation to target the ocular surface.
Research
Study ties magnesium to reduced RVO risk
Sufficient magnesium intake significantly reduced risk of RVO, particularly in three key subgroups.
Products
Gore launches silicone-free syringe plunger for prefilled syringes
The 0.5 mL GORE IMPROJECT plunger is specially designed for use in various silicon-sensitive clinical applications—including IVT injections.
Pipeline
Qlaris Bio developing fixed-dose latanoprost and QLS-111 eye drop for glaucoma
New combination therapy involving the prostaglandin analog targets lowering episcleral venous pressure to lower IOP.
Pipeline
SpyGlass Pharma raises $75M to advance sustained-release drug delivery platform
Financing to support upcoming phase 3 trials on the company’s long-term delivery system of bimatoprost for glaucoma and OHT treatment.
Research
Does silicone oil cause macular edema post-RRD surgery?
Study identifies two key factors that may significantly increase the risk for macular edema development.
Pipeline
FDA clears IND for Zhaoke Ophthalmology's CsA ophthalmic gel
Clearance paves the way for a new phase 3 trial to evaluate CsA 0.05% for its safety and efficacy among moderate-to-severe DED patients—with plans for an eventual NDA submission.
Products
Coburn Technologies debuts the Huvitz HVS-1 Vision Screener
Handheld portable device assesses refractive errors in just 1 second, providing non-contact and precise measurements for pediatric and elderly patients.
Products
Harrow acquires U.S. rights to clobetasol propionate for postop inflammation and pain
Commercial rights for the newly-named BYQLOVI reportedly purchased from Formosa; plans include a Q4 2025 launch.
Pipeline
ViGeneron rebrands as VeonGen Therapeutics with new FDA designation
German-based genetic medicine company also receives a Rare Pediatric Disease Designation for its Sargardt disease gene therapy candidate.
Research
Vitamin D may benefit pediatric keratoconus progression
Study joins growing body of literature suggesting that KC is an ocular manifestation of a systemic disorder.
Products
Haag-Streit launches corneal map for the Lenstar 900
The optical biometer’s newest integratable feature enables simultaneous measurement of a wider range of biometric parameters for cataract surgery planning.
Pipeline
iVeena submits IND to FDA for pediatric myopia clinical trial
Company plans to initiate a multinational phase 2 study on IVMED-85, a PF and non-atropine daily eye drop intended to improve refraction and decrease AE rates.
Research
TFOS releases DEWS III Diagnostic Methodology report
Authors of the latest Dry Eye Workshop report call for a simplified patient screening questionnaire, a revised symptomatic DED definition, and updates to risk factors.
Research
Does patching after age 4 benefit unilateral congenital cataract patients?
Visual acuity at age 4 was a reliable predictor of final visual outcomes in children with unilateral congenital cataracts.
Products
Bausch + Lomb launches two new eye drops to Blink portfolio
Now available at most U.S. retailers, the latest additions to this specialty product line includes Blink Nourish Lubricating and Blink Boost Lubricating eye drops.
Products
Eschenbach Optik launches blue light readers with anti-fog tech
New line of reading glasses block a reported 30% of blue-violet light and feature lenses with anti-fog coating and impact-resistant material for lasting durability.
Research
Longtime declining global trachoma rate now on the rise
Study highlights geographical distribution and health inequalities in worldwide disease burden.
Pipeline